That's what you get when your economy is growing at a rate of 10.1%.
Their biggest worries? Inflation, followed by corruption among both public officials and business leaders.
Meanwhile, here in the U.S., only 20% of Americans are optimistic about their future, and both Congress and the president recently earned their worst approval ratings ever!
How can the Chinese be so happy, we ask, when their human rights policies are so backward?
How we can be so pessimistic, the Chinese ask, when we have so much?
In both cases, the answer lies not in where we are but in where we believe we are going.
Happy Chinese and Unhappy Americans
The Chinese, noting how far they have come in recent years, and how far they are likely to go in the years ahead, cannot help but be optimistic. The future is bright, and credit for this, rightly or not, is ascribed to their leaders.
Human rights? That's our yardstick, not theirs. For them, the more important yardsticks are how much food is on the table, the state of their housing, their ability to buy a new bicycle, scooter or car, and the amount of their pay relative to the hours worked. For them, life is getting better all the time.
Here in the U.S., we are rich; there's no doubt about that. Our per capita income is about $42,000, eighth among developed nations, and behind a few select countries like Luxembourg, Qatar and Iceland. If wealth were all that mattered we'd be delirious. But we feel increasingly burdened by debt, and, more important--burdened by the growing realization that our rate of growth is inexorably slowing. For the first time, perhaps, there's a fear that our children's lives will not be as rich as our own.
So what are we to do?
Turbocharge our economy by ignoring individual human rights?
Convert to communism and elect leaders who operate as China's do?
Or, as Bobby McFerrin sang, "Don't worry, be happy"?
No, no and maybe.
There's no way we're going to backtrack on the progress we've made on individual rights. In the long run, we're on the right path. China will get there eventually.
Communism is a non-starter. Fact is, China is booming today because it has embraced capitalism.
And as for Bobby McFerrin's advice? Well, as I write this, I'm sitting in the Fort Lauderdale, Florida, airport, filling a few hours by writing this Cabot Wealth Advisory a couple of days before it's due. I'm healthy, my stomach is content, I've got my favorite tunes playing in my ears through my 3G iPhone, and my loving family at home awaits my return. I'm happy.
But I recognize that America as a whole has lot to complain about today, and does complain about a lot today, and because of this I have three pieces of advice.
The first is this: look on the bright side. Look beyond the headlines to find the good news. Be thankful that you are healthy, educated, well fed ... and free.
The second is this: vote the bums out. If you agree with me that poor management by our elected officials is responsible for some of our national malaise, then dare to vote for someone who will manage differently.
The third is this: invest in American stocks now ... or next month. The exact timing is unimportant, but the point is this. American stocks are cheap now; after a nine-month bear market, it's time for the new bull to be born. The fact that Americans feel so bad about their economy supports that conclusion!
"The Point of Peak Perception"
The worst time to invest in a company or a country is when it is well loved, when it's at "The Point of Peak Perception." That's when it is most expensive!
For Sears, Roebuck and Co., this point came in 1973. Revenues and earnings kept growing for many more years, but the stock got no higher. The dividend was finally cut in 1993. For Polaroid as well, the "The Point of Peak Perception" came in 1973, 19 years before earnings peaked and long before it became evident that digital photography and stuck-in-the-mud management would kill the company.
At the time these stocks peaked they were widely loved; their managements were revered as geniuses, and expectations were that the good times would continue. But when everyone thinks alike, the market has a way of proving them wrong. After all investors have bought, the sellers eventually take control. After you're #1, there's only one way to go.
That's one reason the dollar, which you might view as a proxy for the value of the U.S., is down. It was previously perceived to be the most powerful currency on earth; in recent years its reputation has been in decline.
But I'm firmly convinced the long-term trend of the U.S. economy--and thus the U.S. stock market--is still up, and that the market will reflect that by climbing out to new highs eventually. And the time to invest is when public perception is lowest! It seems to me we're pretty much there.
--- Advertisement ---
Make Double Digit Profits on Less Than a Dollar a Day
Cabot Green Investor applies our time-tested growth stock picking and market timing systems to the next generation of investing. Cabot's newest publication has seen double-digit profits in several recommended stocks since the start of the year, despite the market downturn.
Cabot Green Investor has brought in big returns for subscribers, gains like these:
Clean Harbors - up 25% since the early March
American Superconductor - up about 40% in less than three months.
And that's just the beginning ...
The Green sector is new and growing fast, presenting huge opportunities for those who want to get in on the ground floor of an investing revolution. Click the link below to get started today.
Investment-wise, there are two ways you can play this. The first is to buy really cheap stocks of good companies. The second is to invest in far younger stocks of faster-growing companies; companies that have the potential lead the market for years to come.
Here's one, which was recommended two weeks ago in Cabot Top Ten Report. Its name is Myriad Genetics (MYGN), and it's a biopharmaceutical company that's working at the molecular level to tackle some very big ailments. Here's what Editor Michael Cintolo wrote:
"Up to this point, the company's products have been diagnostics tests that determine an individual's genetic risk of developing certain kinds of cancer. Although Myriad has never made a profit, revenue growth has been impressive and the company projects that it will reach profitability by the end of its next fiscal year on June 30, 2009. With all that said, it's the potential of the treatments in clinical trials that's attracting investors' attention. In addition to four drugs in preclinical development, Myriad has three drugs (for HIV, thrombosis and cancer) in phase 1 and three (for glioblastoma, melanoma and non-small-cell lung cancer) in phase 2."
When Mike wrote that, MYGN was trading at 58. In the days since then it's kept climbing; it hit 65 today! The stock is telling us the future for this company is very bright, and there's no doubt the earnings report on August 19 will confirm that. Just beware that earnings reports can spark big short-term moves ... in either direction.
Editor's Note: Myriad Genetics is just one of dozens of examples of exciting young growth stocks found in Cabot Top Ten Report. This momentum-centric advisory, published every Monday, is your ticket to the hottest stocks in the market, perhaps the next Baidu, DryShips or Illumina. To get started with a no-risk trial subscription, simply click the link below.
Yours in pursuit of wisdom and wealth,
Cabot Wealth Advisory